Cell biology and pathology of podocytes

Annual Review of Physiology

Volumn 74, Issue , 2012, Pages 299-323

  Greka, Anna ^a   Mundel, Peter ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Actin cytoskeleton; Angiotensin; Autophagy; Calcium; Foot process; Glomerulus; Integrins; MTOR; Rac1; RhoA; Slit diaphragm; Synaptopodin; TRPC channels

Indexed keywords

BETA CATENIN; CD2 ASSOCIATED PROTEIN; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR RECEPTOR; MULTIPROTEIN COMPLEX; NEPHRIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ACUTE KIDNEY FAILURE; ARTICLE; BASEMENT MEMBRANE; BOWMAN CAPSULE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CHRONIC KIDNEY FAILURE; CYTOLOGY; CYTOSKELETON; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; INTERSTITIAL NEPHRITIS; NEPHROBLASTOMA; PODOCYTE; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL;

EID: 84857243208     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-020911-153238     Document Type: Article

References (198)

1. Mundel P, Kriz W. 1995. Structure and function of podocytes: an update. Anat. Embryol. 192:385-97
2. Somlo S, Mundel P. 2000. Getting a foothold in nephrotic syndrome. Nat. Genet. 24:333-35 (Pubitemid 30187426)
3. Drenckhahn D, Franke RP. 1988. Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab. Investig. 59:673-82 (Pubitemid 19009729)
4. Kerjaschki D. 2001. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J. Clin. Investig. 108:1583-87 (Pubitemid 33144868)
5. Takeda T, McQuistan T, Orlando RA, Farquhar MG. 2001. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J. Clin. Investig. 108:289-301 (Pubitemid 32656253)
6. Schmieder S, Nagai M, Orlando RA, Takeda T, Farquhar MG. 2004. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin inMDCK cells. J. Am. Soc. Nephrol. 15:2289-98 (Pubitemid 39159329)
7. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. 2007. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 17:428-37 (Pubitemid 47499042)
8. Tryggvason K, Patrakka J, Wartiovaara J. 2006. Hereditary proteinuria syndromes and mechanisms of proteinuria. N. Engl. J. Med. 354:1387-401
9. Saxen L, Sariola H. 1987. Early organogenesis of the kidney. Pediatr. Nephrol. 1:385-92 (Pubitemid 18016633)
10. Sorokin L, Ekblom P. 1992. Development of tubular and glomerular cells of the kidney. Kidney Int. 41:657-64
11. Reeves W, Caulfield JP, Farquhar MG. 1978. Differentiation of epithelial foot processes and filtration slits: sequential appearance of occluding junctions, epithelial polyanion, and slit membranes in developing glomeruli. Lab. Investig. 39:90-100 (Pubitemid 9004938)
12. Schnabel E, Dekan G, Miettinen A, Farquhar MG. 1989. Biogenesis of podocalyxin-the major glomerular sialoglycoprotein-in the newborn rat kidney. Eur. J. Cell Biol. 48:313-26 (Pubitemid 19127296)
13. Schnabel E, Anderson JM, Farquhar MG. 1990. The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J. Cell Biol. 111:1255-63
14. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B. 1993. Nuclear localization of the protein encoded by the Wims tumor gene WT1 in embryonic and adult tissues. Development 119:1329-41 (Pubitemid 23358597)
15. Reiser J, Kriz W, Kretzler M, Mundel P. 2000. The glomerular slit diaphragm is a modified adherens junction. J. Am. Soc. Nephrol. 11:1-8 (Pubitemid 30020420)
16. Hartleben B, Schweizer H, Lubben P, Bartram MP, Moller CC, et al. 2008. Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J. Biol. Chem. 283:23033-38
17. Huber TB, Hartleben B, Winkelmann K, Schneider L, Becker JU, et al. 2009. Loss of podocyte aPKCλ/? causes polarity defects and nephrotic syndrome. J. Am. Soc. Nephrol. 20:798-806
18. Hirose T, Satoh D, Kurihara H, Kusaka C, Hirose H, et al. 2009. An essential role of the universal polarity protein, aPKCλ, on the maintenance of podocyte slit diaphragms. PLoS ONE 4:e4194
19. Mundel P, Gilbert P, Kriz W. 1991. Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J. Histochem. Cytochem. 39:1047-56
20. Holthofer H, Miettinen A, Lehto VP, Lehtonen E, Virtanen I. 1984. Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab. Investig. 50:552-29
21. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, et al. 1996. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537-47 (Pubitemid 26395995)
22. Kanasaki K, Kanda Y, Palmsten K, Tanjore H, Lee SB, et al. 2008. Integrinβ1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev. Biol. 313:584-93
23. Pozzi A, Jarad G, Moeckel GW, Coffa S, Zhang X, et al. 2008. β1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev. Biol. 316:288-301
24. Ciani L, Patel A, Allen ND, Ffrench-Constant C. 2003. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol. Cell. Biol. 23:3575-82 (Pubitemid 36539190)
25. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, et al. 1998. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1:575-82 (Pubitemid 128374693)
26. Jones N, Blasutig IM, Eremina V, Ruston JM, Bladt F, et al. 2006. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 440:818-23
27. Brakebusch C, Fassler R. 2003. The integrin-actin connection, an eternal love affair. EMBO J. 22:2324-33 (Pubitemid 36604972)
28. Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, et al. 2001. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J. Exp. Med. 194:13-27 (Pubitemid 32660434)
29. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, et al. 2000. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24:349-54 (Pubitemid 30187431)
30. Sadl V, Jin F, Yu J, Cui S, Holmyard D, et al. 2002. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev. Biol. 249:16-29
31. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, et al. 1999. The basic-helix-loop-helix protein Pod1 is critically important for kidney and lung organogenesis. Development 126:5771-83 (Pubitemid 30035024)
32. Pabst R, Sterzl RB. 1983. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int. 24:626-31 (Pubitemid 14208758)
33. Kriz W, Elger M, Kretzler M, Uiker S, Koeppen-Hagemann I, et al. 1994. The role of podocytes in the development of glomerular sclerosis. Kidney Int. 45:S64-72
34. Nagata M, Yamaguchi Y, Komatsu Y, Ito K. 1995. Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 70:68-71
35. Rasch R, Norgaard JO. 1983. Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 25:280-87 (Pubitemid 13002128)
36. Fries JW, Sandstrom DJ, Meyer TW, Rennke HG. 1989. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab. Investig. 60:205-18 (Pubitemid 19072404)
37. Barisoni L, Kriz W, Mundel P, DAgati V. 1999. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 10:51-61 (Pubitemid 29034942)
38. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P. 2000. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int. 58:137-43 (Pubitemid 30429858)
39. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, et al. 2002. HIV-1Nef induces proliferation and anchorage-independent growth in podocytes. J. Am. Soc. Nephrol. 13:1806-15 (Pubitemid 34700605)
40. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, DAgati V, Alpers CE. 2000. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int. 58:674-83 (Pubitemid 30620016)
41. Shankland SJ, Wolf G. 2000. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol. Ren. Physiol. 278:515-29
42. Kriz W, Gretz N, Lemley KV. 1998. Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int. 54:687-97 (Pubitemid 28397387)
43. Smeets B, Uhlig S, Fuss A, Mooren F, Wetzels JF, et al. 2009. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J. Am. Soc. Nephrol. 20:2604-15
44. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, et al. 2009. Recruitment of podocytes from glomerular parietal epithelial cells. J. Am. Soc. Nephrol. 20:333-43
45. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, et al. 2011. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 22:1262-74
46. Kennedy MB. 1993. The postsynaptic density. Curr. Opin. Neurobiol. 3:732-37 (Pubitemid 23303377)
47. Kim E, Sheng M. 2004. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5:771-81 (Pubitemid 39336214)
48. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, et al. 2005. TRPC6is a glomerular slit diaphragmassociated channel required for normal renal function. Nat. Genet. 37:739-44 (Pubitemid 41754891)
49. Durvasula RV, Shankland SJ. 2006. Podocyte injury and targeting therapy: an update. Curr. Opin. Nephrol. Hypertens. 15:1-7
50. Tryggvason K, Pikkarainen T, Patrakka J. 2006. Nck links nephrin to actin in kidney podocytes. Cell 125:221-24
51. Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB. 2006. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J. Clin. Investig. 116:1346-59
52. Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, et al. 2003. Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin. J. Biol. Chem. 278:20716-23 (Pubitemid 36806374)
53. Zhu J, Sun N, Aoudjit L, Li H, Kawachi H, et al. 2008. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int. 73:556-66 (Pubitemid 351264104)
54. Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, et al. 2007. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: Retrieval is disrupted in nephrotic states. Kidney Int. 71:504-13 (Pubitemid 46398675)
55. Tanner GA. 2009. Glomerular sieving coefficient of serum albumin in the rat: a two-photon microscopy study. Am. J. Physiol. Ren. Physiol. 296:1258-65
56. Tanner GA, Rippe C, Shao Y, Evan AP, Williams JC Jr. 2009. Glomerular permeability to macromolecules in the Necturus kidney. Am. J. Physiol. Ren. Physiol. 296:1269-78
57. Peti-Peterdi J. 2009. Independent two-photon measurements of albumin GSC give low values. Am. J. Physiol. Ren. Physiol. 296:1255-57
58. Haraldsson B, JeanssonM. 2009. Glomerular filtration barrier. Curr. Opin. Nephrol. Hypertens. 18:331-35
59. Haraldsson B, Nystrom J, Deen WM. 2008. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88:451-87 (Pubitemid 351522745)
60. Navar LG. 2009. Glomerular permeability: a never-ending saga. Am. J. Physiol. Ren. Physiol. 296:1266-68
61. Tryggvason K, Wartiovaara J. 2001. Molecular basis of glomerular permselectivity. Curr. Opin. Nephrol. Hypertens. 10:543-49 (Pubitemid 32664707)
62. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, et al. 2000. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24:251-56 (Pubitemid 30132192)
63. Simons M, Schwarz K, Kriz W, Miettinen A, Reiser J, et al. 2001. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am. J. Pathol. 159:1069-77 (Pubitemid 32847197)
64. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, et al. 2008. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14:55-63
65. Regele HM, Fillipovic E, Langer B, Poczewki H, Kraxberger I, et al. 2000. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 11:403-12 (Pubitemid 30115070)
66. Raats CJ, Bakker MA, van den Born J, Berden JH. 1997. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J. Biol. Chem. 272:26734-41 (Pubitemid 27458901)
67. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP. 1995. The renal glomerulus of mice lacking s-laminin/laminin β2: nephrosis despite molecular compensation by laminin β1. Nat. Genet. 10:400-6
68. Kretzler M, Teixeira VP, Unschuld PG, Cohen CD, Wanke R, et al. 2001. Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J. 15:1843-45
69. Lorenzen J, Shah R, Biser A, Staicu SA, Niranjan T, et al. 2008. The role of osteopontin in the development of albuminuria. J. Am. Soc. Nephrol. 19:884-90
70. Sachs N, Kreft M, van den Bergh Weerman MA, Beynon AJ, Peters TA, et al. 2006. Kidney failure in mice lacking the tetraspanin CD151. J. Cell Biol. 175:33-39 (Pubitemid 44537196)
71. Tian D, Jacobo SM, Billing D, Rozkalne A, Gage SD, et al. 2010. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci. Signal. 3:ra77
72. Vassiliadis J, Bracken C, Matthews D, OBrien S, Schiavi S, Wawersik S. 2011. Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling. J. Am. Soc. Nephrol. 22:1453-61
73. Smoyer WE, Mundel P. 1998. Regulation of podocyte structure during the development of nephrotic syndrome. J. Mol. Med. 76:172-83 (Pubitemid 28098703)
74. Kos CH, Le TC, Sinha S, Henderson JM, Kim SH, et al. 2003. Mice deficient in α-actinin-4 have severe glomerular disease. J. Clin. Investig. 111:1683-90 (Pubitemid 38057750)
75. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, et al. 2008. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14:1370-76
76. Lu TC, He JC, Wang ZH, Feng X, Fukumi-Tominaga T, et al. 2008. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J. Biol. Chem. 283:8173-82
77. Orlando RA, Takeda T, Zak B, Schmieder S, Benoit VM, et al. 2001. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J. Am. Soc. Nephrol. 12:1589-98 (Pubitemid 32674420)
78. Galeano B, Klootwijk R, Manoli I, Sun M, Ciccone C, et al. 2007. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J. Clin. Investig. 117:1585-94 (Pubitemid 46871343)
79. Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T. 2006. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 47:1084-93 (Pubitemid 44289165)
80. Navarro-Munoz M, Ibernon M, Perez V, Ara J, Espinal A, et al. 2011. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal change disease and focal segmental glomerulosclerosis in adult patients. Nephrol. Dial. Transplant. In press
81. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, et al. 2004. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J. Clin. Investig. 113:1390-97 (Pubitemid 39071694)
82. Asanuma K, Shirato I, Ishidoh K, Kominami E, Tomino Y. 2002. Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. Kidney Int. 62:822-31 (Pubitemid 35316711)
83. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, et al. 2008. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14:931-38
84. Reiser J, Oh J, Shirato I, Asanuma K, Hug A, et al. 2004. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and α3 integrin. J. Biol. Chem. 279:34827-32 (Pubitemid 39318116)
85. Ronco P. 2007. Proteinuria: Is it all in the foot? J. Clin. Investig. 117:2079-82
86. Sever S, Altintas MM, Nankoe SR, Moller CC, Ko D, et al. 2007. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J. Clin. Investig. 117:2095-104 (Pubitemid 47219554)
87. Quaggin SE. 2002. Transcriptional regulation of podocyte specification and differentiation. Microsc. Res. Tech. 57:208-11 (Pubitemid 34553250)
88. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, et al. 2003. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Investig. 111:707-16 (Pubitemid 36278589)
89. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, et al. 2008. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358:1129-36 (Pubitemid 351398487)
90. Böttinger EP, Bitzer M. 2002. TGF-βsignaling in renal disease. J. Am. Soc. Nephrol. 13:2600-10
91. Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N. 2004. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J. Am. Soc. Nephrol. 15:1475-87 (Pubitemid 38679672)
92. Hsu HH, Hoffmann S, Endlich N, Velic A, Schwab A, et al. 2008. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J. Mol. Med. 86:1379-94
93. Gloy J, Henger A, Fischer KG, Nitschke R, Mundel P, et al. 1997. Angiotensin II depolarizes podocytes in the intact glomerulus of the rat. J. Clin. Investig. 99:2772-81 (Pubitemid 27259825)
94. Waters AM, Wu MY, Onay T, Scutaru J, Liu J, et al. 2008. Ectopic Notch activation in developing podocytes causes glomerulosclerosis. J. Am. Soc. Nephrol. 19:1139-57
95. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, et al. 2008. TheNotch pathway in podocytes plays a role in the development of glomerular disease. Nat. Med. 14:290-98 (Pubitemid 351347919)
96. Kreidberg JA. 2000. Functions of α3β1 integrin. Curr. Opin. Cell Biol. 12:548-53
97. Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, et al. 2011. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat. Med. 17:117-22
98. Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, et al. 2011. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am. J. Pathol. 179:1719-32
99. Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, et al. 2011. TRPC6 enhances angiotensin II-induced albuminuria. J. Am. Soc. Nephrol. 22:526-35
100. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, et al. 2005. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801-4 (Pubitemid 40848011)
101. Kriz W, LeHir M. 2005. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 67:404-19 (Pubitemid 40139832)
102. Mundel P, Shankland SJ. 2002. Podocyte biology and response to injury. J. Am. Soc. Nephrol. 13:3005-15 (Pubitemid 35386921)
103. Zandi-Nejad K, Eddy AA, Glassock RJ, Brenner BM. 2004. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int. 66:S76-89 (Pubitemid 43361438)
104. Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, et al. 2005. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am. J. Pathol. 166:1309-20 (Pubitemid 40586503)
105. Wilmer WA, Rovin BH, Hebert CJ, Rao SV, Kumor K, Hebert LA. 2003. Management of glomerular proteinuria: a commentary. J. Am. Soc. Nephrol. 14:3217-32 (Pubitemid 37509297)
106. Kikuchi H, Kawachi H, Ito Y, Matsui K, Nosaka H, et al. 2000. Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis. Nephrol. Dial. Transplant. 15:799-810 (Pubitemid 30311997)
107. Kriz W, Hartmann I, Hosser H, Hahnel B, Kranzlin B, et al. 2001. Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12:496-506 (Pubitemid 32180018)
108. Gross ML, Hanke W, Koch A, Ziebart H, Amann K, Ritz E. 2002. Intraperitoneal protein injection in the axolotl: the amphibian kidney as a novel model to study tubulointerstitial activation. Kidney Int. 62:51-59 (Pubitemid 34754047)
109. Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, et al. 2006. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38:1397-405 (Pubitemid 44837561)
110. Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, et al. 2011. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Investig. 121:2013-24
111. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, et al. 2003. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300:1298-300 (Pubitemid 36618242)
112. Brown EJ, Schlondorff JS, Becker DJ, Tsukaguchi H, Uscinski AL, et al. 2010. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42:72-76
113. Heeringa SF, Moller CC, Du J, Yue L, Hinkes B, et al. 2009. A novel TRPC6 mutation that causes childhood FSGS. PLoS ONE 4:e7771
114. Dai S, Wang Z, Pan X, Wang W, Chen X, et al. 2010. Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 25:824-35
115. Morello R, Zhou G, Dreyer SD, Harvey SJ, Ninomiya Y, et al. 2001. Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome. Nat. Genet. 27:205-8 (Pubitemid 32157450)
116. Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, et al. 2004. Human laminin β2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet. 13:2625-32 (Pubitemid 39485411)
117. Mele C, Iatropoulos P, Donadelli R, Calabria A, Maranta R, et al. 2011. MYO1Emutations and childhood familial focal segmental glomerulosclerosis. N. Engl. J. Med. 365:295-306
118. Sanna-Cherchi S, Burgess KE, Nees SN, Caridi G, Weng PL, et al. 2011. Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int. 80:389-96
119. Togawa A, Miyoshi J, Ishizaki H, Tanaka M, Takakura A, et al. 1999. Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIα. Oncogene 18:5373-80 (Pubitemid 29469225)
120. Moeller MJ, Soofi A, Braun GS, Li X, Watzl C, et al. 2004. Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J. 23:3769-79 (Pubitemid 39389708)
121. Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, et al. 2005. Synaptopodin regulates the actin-bundling activity of α-actinin in an isoform-specific manner. J. Clin. Investig. 115:1188-98 (Pubitemid 40629037)
122. Asanuma K, Yanagida-Asanuma E, Faul C, Tomino Y, Kim K, Mundel P. 2006. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat. Cell Biol. 8:485-91
123. Garg P, Verma R, Cook L, Soofi A, Venkatareddy M, et al. 2010. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. J. Biol. Chem. 285:22676-88
124. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. 2008. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 40:1185-92
125. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. 2008. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 40:1175-84
126. Arrondel C, Vodovar N, Knebelmann B, Grunfeld JP, Gubler MC, et al. 2002. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J. Am. Soc. Nephrol. 13:65-74 (Pubitemid 34042012)
127. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. 2010. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841-45
128. Okamoto K, Tokunaga K, Doi K, Fujita T, Suzuki H, et al. 2011. Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat. Genet. 43:459-63
129. Garg P, Verma R, Nihalani D, Johnstone DB, Holzman LB. 2007. Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol. Cell. Biol. 27:8698-712
130. Kerjaschki D. 1978. Polycation-induced dislocation of slit diaphragms and formation of cell junctions in rat kidney glomeruli. The effects of low temperature, divalent cations, colchicine, and cytochalasin B. Lab. Investig. 39:430-40 (Pubitemid 9095299)
131. Cybulsky AV, Bonventre JV, Quigg RJ, Lieberthal W, Salant DJ. 1990. Cytosolic calcium and protein kinase C reduce complement-mediated glomerular epithelial injury. Kidney Int. 38:803-11 (Pubitemid 20362846)
132. Seiler MW, Rennke HG, Venkatachalam MA, Cotran RS. 1977. Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab. Investig. 36:48-61 (Pubitemid 8021270)
133. Seiler MW, Venkatachalam MA, CotranRS. 1975. Glomerular epithelium: structural alterations induced by polycations. Science 189:390-93
134. Rudiger F, Greger R, Nitschke R, Henger A, Mundel P, PavenstadtH. 1999. Polycations induce calcium signaling in glomerular podocytes. Kidney Int. 56:1700-9 (Pubitemid 29518170)
135. Mundel P, Reiser J, Kriz W. 1997. Induction of differentiation in cultured rat and human podocytes. J. Am. Soc. Nephrol. 8:697-705 (Pubitemid 27493583)
136. Henger A, Huber T, Fischer KG, Nitschke R, Mundel P, et al. 1997. Angiotensin II increases the cytosolic calcium activity in rat podocytes in culture. Kidney Int. 52:687-93 (Pubitemid 27402367)
137. Oh J, Beckmann J, Bloch J, Hettgen V, Mueller J, et al. 2011. Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int. 80:483-92
138. Schlondorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR. 2009. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation ofNFAT-dependent transcription. Am. J. Physiol. Cell Physiol. 296:58-69
139. Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, et al. 2010. Activation of NFAT signaling in podocytes causes glomerulosclerosis. J. Am. Soc. Nephrol. 21:1657-66
140. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, et al. 2006. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J. Clin. Investig. 116:3114-26 (Pubitemid 44878626)
141. Onohara N, Nishida M, Inoue R, Kobayashi H, Sumimoto H, et al. 2006. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 25:5305-16 (Pubitemid 44764140)
142. Wu X, Eder P, Chang B, Molkentin JD. 2010. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 107:7000-5
143. Chen J, Chen JK, Neilson EG, Harris RC. 2006. Role of EGF receptor activation in angiotensin IIinduced renal epithelial cell hypertrophy. J. Am. Soc. Nephrol. 17:1615-23 (Pubitemid 43794664)
144. Flannery PJ, Spurney RF. 2006. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. Nephron Exp. Nephrol. 103:e109-18 (Pubitemid 43952616)
145. Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, et al. 1999. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J. Am. Soc. Nephrol. 10(Suppl. 11):57-61
146. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, et al. 2001. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345:861-69
147. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, et al. 2001. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345:851-60
148. Aspenstrom P, Fransson A, Saras J. 2004. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 377:327-37 (Pubitemid 38142188)
149. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-35 (Pubitemid 36764489)
150. Yanagida-Asanuma E, Asanuma K, Kim K, Donnelly M, Young Choi H, et al. 2007. Synaptopodin protects against proteinuria by disruptingCdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am. J. Pathol. 171:415-27 (Pubitemid 47344675)
151. Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, et al. 2010. Podocyte-specific overexpression of wild type or mutant Trpc6 in mice is sufficient to cause glomerular disease. PLoS ONE 5:e12859
152. Zhu L, Jiang R, Aoudjit L, Jones N, Takano T. 2011. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 22:1621-30
153. Dietrich A, Mederos YSM, Gollasch M, Gross V, Storch U, et al. 2005. Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol. Cell. Biol. 25:6980-89 (Pubitemid 41105898)
154. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110:673-87 (Pubitemid 35283958)
155. Arnaout MA, Mahalingam B, Xiong JP. 2005. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21:381-410 (Pubitemid 41740640)
156. Kerjaschki D, Ojha PP, Susani M, Horvat R, Binder S, et al. 1989. Aβ1-integrin receptor for fibronectin in human kidney glomeruli. Am. J. Pathol. 134:481-89 (Pubitemid 19063905)
157. Schordan S, Schordan E, Endlich K, Endlich N. 2011. αv-Integrins mediate the mechanoprotective action of osteopontin in podocytes. Am. J. Physiol. Ren. Physiol. 300:119-32
158. Raats CJ, van Den Born J, Bakker MA, Oppers-Walgreen B, Pisa BJ, et al.
159. Kambham N, Tanji N, Seigle RL, Markowitz GS, Pulkkinen L, et al. 2000. Congenital focal segmental glomerulosclerosis associated with β4 integrin mutation and epidermolysis bullosa. Am. J. Kidney Dis. 36:190-96 (Pubitemid 30432582)
160. Wei C, El Hindi S, Li J, Fornoni A, Goes N, et al. 2011. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17:952-60
161. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, et al. 1996. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J. Med. 334:878-83 (Pubitemid 26107345)
162. Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, et al. 2011. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci. Transl. Med. 3:85ra46
163. Blattner SM, KretzlerM. 2005. Integrin-linked kinase in renal disease: connecting cell-matrix interaction to the cytoskeleton. Curr. Opin. Nephrol. Hypertens. 14:404-10 (Pubitemid 40863081)
164. El-Aouni C, Herbach N, Blattner SM, Henger A, Rastaldi MP, et al. 2006. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J. Am. Soc. Nephrol. 17:1334-44 (Pubitemid 43673413)
165. Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, et al. 2006. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J. Am. Soc. Nephrol. 17:2164-75 (Pubitemid 44141906)
166. de Paulo V, Teixeira C, Blattner SM, Li M, Anders HJ, et al. 2005. Functional consequences of integrinlinked kinase activation in podocyte damage. Kidney Int. 67:514-23 (Pubitemid 40139843)
167. Yang Y, Guo L, Blattner SM, Mundel P, Kretzler M, Wu C. 2005. Formation and phosphorylation of the PINCH-1-integrin linked kinase-α-parvin complex are important for regulation of renal glomerular podocyte adhesion, architecture, and survival. J. Am. Soc. Nephrol. 16:1966-76 (Pubitemid 41716427)
168. Ma H, Togawa A, Soda K, Zhang J, Lee S, et al. 2010. Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J. Am. Soc. Nephrol. 21:1145-56
169. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704 (Pubitemid 351600389)
170. Wullschleger S, Loewith R, Hall MN. 2006. TOR signaling in growth and metabolism. Cell 124:471-84 (Pubitemid 43199434)
171. Vollenbroker B, George B, Wolfgart M, Saleem MA, Pavenstadt H, Weide T. 2009. mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes. Am. J. Physiol. Ren. Physiol. 296:418-26
172. Biancone L, Bussolati B, Mazzucco G, Barreca A, Gallo E, et al. 2010. Loss of nephrin expression in glomeruli of kidney-transplanted patients under m-TOR inhibitor therapy. Am. J. Transplant. 10:2270-78
173. Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, et al. 2011. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Investig. 121:2197-209
174. Inoki K, Mori H, Wang J, Suzuki T, Hong S, et al. 2011. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Investig. 121:2181-96
175. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, et al. 2011. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332:966-70
176. Ashcroft FM. 2006. From molecule to malady. Nature 440:440-47
177. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, et al. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 60:509-20
178. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. 1990. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-78
179. Huang A, Campbell CE, Bonetta L, McAndrews-Hill MS, Chilton-MacNeill S, et al. 1990. Tissue, developmental, and tumor-specific expression of divergent transcripts inWilms tumor. Science 250:991-94 (Pubitemid 120031806)
180. Bonetta L, Kuehn SE, Huang A, Law DJ, Kalikin LM, et al. 1990. Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science 250:994-97 (Pubitemid 120031807)
181. Miner JH, Morello R, Andrews KL, Li C, Antignac C, et al. 2002. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J. Clin. Investig. 109:1065-72 (Pubitemid 34408581)
182. Rohr C, Prestel J, Heidet L, Hosser H, Kriz W, et al. 2002. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J. Clin. Investig. 109:1073-82 (Pubitemid 34408582)
183. Takemoto M, He L, Norlin J, Patrakka J, Xiao Z, et al. 2006. Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J. 25:1160-74 (Pubitemid 43372128)
184. Moriguchi T, Hamada M, Morito N, Terunuma T, Hasegawa K, et al. 2006. MafB is essential for renal development and F4/80 expression in macrophages. Mol. Cell. Biol. 26:5715-27 (Pubitemid 44134328)
185. Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J. 1996. The paired-box transcription factor, PAX2, positivelymodulates expression of theWilms tumor suppressor gene (WT1). Oncogene 13:447-53 (Pubitemid 26283840)
186. Ryan G, Steele-Perkins V, Morris JF, Rauscher FJ 3rd, Dressler GR. 1995. Repression of Pax-2 byWT1 during normal kidney development. Development 121:867-75
187. Clement LC, Liu G, Perez-Torres I, Kanwar YS, Avila-Casado C, Chugh SS. 2007. Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int. 72:337-47 (Pubitemid 47172374)
188. Liu G, Clement LC, Kanwar YS, Avila-Casado C, Chugh SS. 2006. ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. J. Biol. Chem. 281:39681-92 (Pubitemid 46041927)
189. Cui S, Li C, Ema M, Weinstein J, Quaggin SE. 2005. Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout mice. J. Am. Soc. Nephrol. 16:3247-55 (Pubitemid 46179330)
190. Kumar PA, Kotlyarevska K, Dejkhmaron P, Reddy GR, Lu C, et al. 2010. Growth hormone (GH)- dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of GH with implications for the pathogenesis of diabetic nephropathy. J. Biol. Chem. 285:31148-56
191. Ding M, Cui S, Li C, Jothy S, Haase V, et al. 2006. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat. Med. 12:1081-87 (Pubitemid 44353390)
192. Brukamp K, Jim B, Moeller MJ, Haase VH. 2007. Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease. Am. J. Physiol. Ren. Physiol. 293:1397-407
193. Freeburg PB, Robert B, St John PL, Abrahamson DR. 2003. Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J. Am. Soc. Nephrol. 14:927-38 (Pubitemid 36359275)
194. Heikkila E, Juhila J, Lassila M, Messing M, Perala N, et al. 2010. β-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys. Nephrol. Dial. Transplant. 25:2437-46
195. He W, Kang YS, Dai C, Liu Y. 2011. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J. Am. Soc. Nephrol. 22:90-103
196. Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, et al. 1998. Mutations inLMX1Bcause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat. Genet. 19:47-50 (Pubitemid 28242021)
197. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, et al. 1991. Germline mutations in the Wilms tumor suppressor gene are associated with abnormal urogential development in Denys-Drash syndrome. Cell 67:437-47 (Pubitemid 121001458)
198. Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE. 1991. WT1 mutations contribute to abnormal genital system development and hereditary Wilms tumour. Nature 353:431-34 (Pubitemid 21912529)